FINWIRES · TerminalLIVE
FINWIRES

New Zealand Shares Flat; Taiko Critical Minerals Secures Nearly NZ$8 Million in Capital Raise

By

-- New Zealand shares ended flat and Asian shares were mixed on Wednesday after a sell-off on Wall Street as US-Iran peace talks continue to stall.

The S&P/NZX 50 Index was little changed to close at 12,770.30.

On Tuesday, the S&P fell 0.5%, the Nasdaq lost 0.9%, and the Dow Jones decreased 0.05%.

The United Arab Emirates will leave the Organization of the Petroleum Exporting Countries on Friday, in a move that Rystad Energy said makes the cartel "structurally weaker."

In domestic news, Reserve Bank of New Zealand Governor Anna Breman said New Zealand cannot avoid being "buffeted" by global forces stemming from the Middle East conflict, with the impact to be felt differently across sectors, regions, and households, according to a statement.

Further, house prices in New Zealand rose 0.8% in the three months to March, but are forecast to fall by 2% over 2026, ANZ said

Also, New Zealand saw NZ$54.7 million wiped from property asking prices in the first quarter as sellers priced at levels closer to what buyers expect to pay, according to a Wednesday report from realestate.co.nz.

Meanwhile, total new residential mortgage lending in New Zealand rose to NZ$9.5 billion in March from NZ$6.64 billion in February, according to data from the Reserve Bank of New Zealand released on Wednesday.

Finally, New Zealand's first-quarter unemployment rate is expected to remain steady at 5.4%, slightly lower than the previous forecast of 5.5%, according to a report by ANZ released on Wednesday.

In corporate news, Taiko Critical Minerals (NZE:TCM) reported strong progress in the March quarter, securing NZ$7.9 million through a rights issue and shortfall placement.

Rua Bioscience (NZE:RUA) said the Australian market has experienced "significant contraction" in medical cannabis prescribing volumes amid a Therapeutic Goods Administration review of the safety of unapproved products.

Related Articles

Research

Research Alert: Azn Q1 2026 Beat As Oncology Remains Strong; Reaffirms 2026 Guidance

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:AstraZeneca (AZN) posted 13% total revenue growth (+8% at constant exchange rates, CER) to USD15.3B in Q1 2026, beating consensus estimates of USD14.9B, with oncology remaining the key contributor (+16% CER). Imfinzi climbed 30% CER, supported by multiple new launches, while Enhertu grew 34% CER on continued global demand, with core operating margin remaining broadly stable Y/Y at 35% despite R&D (+8% CER) and SG&A (+7% CER) expense increases. We continue to like AZN for its strong pipeline and numerous key data readouts throughout 2026, supported by four positive Phase 3 trials and 14 regulatory approvals achieved since Q4 2025. AZN reiterated its 2026 guidance for mid- to high-single-digit revenue growth and low double-digit core EPS growth, with currency movements expected to provide modest support. We see this compelling dataset helping support its ambitious target to reach USD80B in total revenue by 2030, with guidance that is more favorable than peers like Novartis.

$AZN
Asia

China Southern Power Grid Energy Storage's Q1 Profit Jumps 21%, Revenue Rises 19%

China Southern Power Grid Energy Storage's (SHA:600995) net profit attributable to shareholders in the first quarter jumped 21% to 453.8 million yuan from almost 374 million yuan a year earlier, according to a Shanghai bourse filing on Wednesday.Earnings per share rose 17% year on year to 0.14 yuan from 0.12 yuan.Operating revenue inched 19% higher to 1.85 billion yuan from 1.56 billion yuan in the previous year.The Chinese state-owned power company's shares closed less than 3% higher.

$SHA:600995
Commodities

European Investment Bank to Advance Ukraine Infrastructure Projects, Including Energy

The European Investment Bank will provide advice on infrastructure development under the a project preparation initiative dubbed Ukraine First, which was created by the European Commission and European Bank for Reconstruction and Development, the EIB said on Tuesday.The EIB will seek to carry forward large-scale infrastructure plans into fully-fledged projects, including some in the energy sector, that are ready to seek financing and construction, it said in a statement.That preparatory work will include feasibility studies, technical design and environmental assessments, the EIB said.Initially, the bank's work will focus on the road network in southern Ukraine, while work will also take place on the restoration of critical infrastructure such as road, energy and railway networks.The EIB signed a deal in Kyiv with the Ukrainian Ministry of Economy, Environment and Agriculture, confirming the cooperation, it said, with a framework now in place for investment projects to take place as Ukraine pursues its ambition of EU membership."This agreement is an important step in supporting Ukraine's recovery and EU accession plans through well-prepared investments," said EIB Vice President Karl Nehammer. "Strong project preparation is essential to ensure that infrastructure investments are delivered efficiently, attract financing and meet European standards."Ukraine First stands for Facility for Infrastructure Reconstruction and it currently has 40 million euros ($46.8 million) in funding available.EIB Advisory will start work on the M15 highway that runs between Odesa in southern Ukraine to the Romanian border, providing a transport plan for the Odesa region and helping to modernize this key road.The EIB has since its 2007 arrival in Ukraine, provided more than 4 billion euros in project financing to the country.